Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bousquet, 1990, Eosinophilic inflammation in asthma, N Engl J Med, 323, 1033, 10.1056/NEJM199010113231505
Coyle, 1995, Human eosinophil granule major basic protein and synthetic polycations induce airway hyperresponsiveness in vivo dependent on bradykinin generation, J Clin Invest, 95, 1735, 10.1172/JCI117850
Sanderson, 1992, Interleukin-5, eosinophils and disease, Blood, 79, 3101, 10.1182/blood.V79.12.3101.bloodjournal79123101
Lampinen, 1999, The role of interleukin-5, interleukin-8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung, Clin Exp Allergy, 29, 314, 10.1046/j.1365-2222.1999.00390.x
Corrigan, 1993, CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations in interleukin-5, Am Rev Respir Dis, 147, 540, 10.1164/ajrccm/147.3.540
Humbert, 1997, Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma, Am J Respir Crit Care Med, 156, 704, 10.1164/ajrccm.156.3.9610033
van der Veen, 1999, The late asthmatic response is associated with baseline allergen-specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin-5, Clin Exp Allergy, 29, 217, 10.1046/j.1365-2222.1999.00466.x
Shi, 1998, Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics, Am J Respir Crit Care Med, 157, 204, 10.1164/ajrccm.157.1.9703027
McKinnon, 1999, Interleukin-5 and the interleukin-5 receptor: targets for drug discovery in asthma, 299
Van Oosterhout, 1993, Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs, Am Rev Respir Dis, 147, 548, 10.1164/ajrccm/147.3.548
Foster, 1996, Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model, J Exp Med, 183, 195, 10.1084/jem.183.1.195
1995, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 152, S77
Taylor, 1998, Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide, Am J Resp Crit Care Med, 158, 99, 10.1164/ajrccm.158.1.9709091
O'Connor, 1992, Tolerance to the nonbronchodilator effects of inhaled ß-agonists in asthma, N Engl J Med, 327, 1204, 10.1056/NEJM199210223271704
Louis, 1997, Cell infiltration, ICAM-1 expression, and eosinophil chemotactic activity in asthmatic sputum, Am J Respir Crit Care Med, 155, 466, 10.1164/ajrccm.155.2.9032180
Taylor, 2000, Comparison of incremental and bolus dose inhaled allergen challenge in asthmatic patients, Clin Exp Allergy, 30, 56, 10.1046/j.1365-2222.2000.00657.x
van der Palen, 1997, Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics, Eur Respir J, 10, 652, 10.1183/09031936.97.10030652
Inman, 1995, Reproducibility of allergen-induced early and late asthmatic responses, J Allergy Clin Immunol, 95, 1191, 10.1016/S0091-6749(95)70075-7
Gauvreau, 1996, Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation, Am J Respir Crit Care Med, 154, 1267, 10.1164/ajrccm.154.5.8912734
Sihra, 1997, Effect of cyclosporin A on the allergen-induced late asthmatic reaction, Thorax, 52, 447, 10.1136/thx.52.5.447
Fahy, 1997, The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects, Am J Respir Crit Care Med, 155, 1828, 10.1164/ajrccm.155.6.9196082
Taylor, 1991, Effect of cysteinyl-leukotriene receptor antagonist ICI 204·219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects, Lancet, 337, 690, 10.1016/0140-6736(91)90277-V
Chapman, 1993, The relationship between inflammation and hyperreactivity of the airways in asthma, Clin Exp Allergy, 23, 168, 10.1111/j.1365-2222.1993.tb00877.x
Foster, 1999, Allergic networks regulating eosinophilia, Am J Respir Cell Mol Biol, 21, 451, 10.1165/ajrcmb.21.4.f167
Mauser, 1993, Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma, Am Rev Respir Dis, 148, 1623, 10.1164/ajrccm/148.6_Pt_1.1623
Mathur, 1999, TRFK-5 reverses established airway eosinophilia but not establised hyperresponsiveness in a murine model of chronic asthma, Am J Respir Crit Care Med, 159, 580, 10.1164/ajrccm.159.2.9712018
Elwood, 1992, Effect of dexamethasone and cyclosporin A on allergen-induced airway hyperresponsiveness and inflammatory cell responses in sensitized Brown-Norway rats, Am Rev Respir Dis, 145, 1289, 10.1164/ajrccm/145.6.1289
Hogan, 1998, A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in balb/c mice independently of IL-4 and IL-5, J Immunol, 161, 1501, 10.4049/jimmunol.161.3.1501
Crimi, 1998, Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma, Am J Resp Crit Care Med, 157, 4, 10.1164/ajrccm.157.1.9703002
Rosi, 1999, Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: results of a factor analysis, J Allergy Clin Immunol, 103, 232, 10.1016/S0091-6749(99)70496-3
Haselden, 2000, Late asthmatic reaction induced by T cell peptides are not associated with eosinophil infiltration of the bronchial mucosa, Am J Respir Crit Care Med, 161, A833
Kips, 2000, Results of a phase 1 trial with SCH55700, a humanized anti-IL-5 antibody, in severe persistent asthma, Am J Respir Crit Care Med, 161, A505